Are Analysts Too Bullish On Arcutis Biotherapeutics Inc (ARQT)
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) currently has a daily average trading volume of 2.03M but it saw 1023990 shares traded in last market. With a market cap of 1.19B USD, the company’s current market price of $10.18 came rising about 0.89 while comparing to the previous closing price of $10.09. In past 52 weeks, the stock […]
Reflections On The Past For Investors Today: Arcutis Biotherapeutics Inc (NASDAQ: ARQT)
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) does about 2.11M shares in volume on a normal day but saw 3018809 shares change hands in the recent trading day. The company now has a market cap of 1.01B USD. Its current market price is $9.26, marking a decrease of -6.75% compared to the previous close of $9.93. The 52 […]
Spotting A Winner: Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Advances 2.15 And It Still Have Room To Run
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) currently has a daily average trading volume of 2.12M but it saw 2276463 shares traded in last market. With a market cap of 1.23B USD, the company’s current market price of $10.47 came rising about 2.15 while comparing to the previous closing price of $10.25. In past 52 weeks, the stock […]
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Now Has A Market Cap Nearing $1.32B But Is Projected To Reach $3.22 billion By 2025
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) does about 2.11M shares in volume on a normal day but saw 4115562 shares change hands in the recent trading day. The company now has a market cap of 1.32B USD. Its current market price is $10.82, marking an increase of 4.04% compared to the previous close of $10.40. The 52 […]
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Emerges As Guiding Light For Investors
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) currently has a daily average trading volume of 2.00M but it saw 3287986 shares traded in last market. With a market cap of 1.13B USD, the company’s current market price of $9.66 came rising about 3.87 while comparing to the previous closing price of $9.30. In past 52 weeks, the stock […]
Stock That Is Worth Exploring Now: Arcutis Biotherapeutics Inc (NASDAQ: ARQT)
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) does about 1.99M shares in volume on a normal day but saw 2054245 shares change hands in the recent trading day. The company now has a market cap of 1.06B USD. Its current market price is $8.67, marking an increase of 4.33% compared to the previous close of $8.31. The 52 […]
Arcutis Biotherapeutics Inc (ARQT): Are Investors Missing The Big Picture?
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) does about 2.05M shares in volume on a normal day but saw 1796732 shares change hands in the recent trading day. The company now has a market cap of 1.02B USD. Its current market price is $8.75, marking an increase of 4.04% compared to the previous close of $8.41. The 52 […]
Arcutis Biotherapeutics Inc (ARQT) At $8.35 Offering A Unique Opportunity
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) currently has a daily average trading volume of 2.05M but it saw 1995350 shares traded in last market. With a market cap of 976.03M USD, the company’s current market price of $8.35 came rising about 0.12 while comparing to the previous closing price of $8.34. In past 52 weeks, the stock […]
Things For Investors To Watch In Arcutis Biotherapeutics Inc (NASDAQ: ARQT)
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) does about 2.01M shares in volume on a normal day but saw 2639274 shares change hands in the recent trading day. The company now has a market cap of 1.02B USD. Its current market price is $8.72, marking a decrease of -8.11% compared to the previous close of $9.49. The 52 […]
It’s Not A Fantasy To Think That Arcutis Biotherapeutics Inc (ARQT) Has Big Future Potential
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) currently has a daily average trading volume of 2.03M but it saw 1092977 shares traded in last market. With a market cap of 1.14B USD, the company’s current market price of $9.72 came rising about 3.96 while comparing to the previous closing price of $9.35. In past 52 weeks, the stock […]
